Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
VolitionRx Limited Announces Acquisition of New Belgian Facility and Appointment of COO to Belgian Volition 2016-10-26 18:30
National Center for Child Health and Development Initiates Phase 1/2 Trial of Green Cross' idursulfase-beta ICV for the Treatment of Hunter Syndrome with Neurocognitive Decline 2016-10-26 10:45
China Biologic Products to Report Third Quarter 2016 Financial Results 2016-10-25 04:15
The US FDA Granted Orphan Drug Designation to Yisheng Biopharma's Biological Product for Hepatocellular Carcinoma 2016-10-24 20:00
VolitionRx Limited Announces Exercise of Over-Allotment Option by Underwriter 2016-10-21 23:34
Adimmune Successfully Places NT$1.5 BN Guaranteed Convertible Bonds 2016-10-21 18:30
CrimsonLogic Simplifies Food and Drug Imports to North America with New Platform 2016-10-20 22:00
PharmaEngine Announces Initiation of Phase 1b/2 Trial of PEP503 (NBTXR3) in Head and Neck Cancer 2016-10-19 23:00
Sinovac Product Pipeline News 2016-10-19 18:00
Biostar Pharmaceuticals Completes Previously Announced Registered Direct Financing 2016-10-19 04:30
PharmaEngine Announces Onivyde(R) Receives European Marketing Authorization for the Treatment of Metastatic Adenocarcinoma of the Pancreas Following Gemcitabine based Therapy 2016-10-18 19:47
China-based TOT BIOPHARM Starts Stage II Construction for Commercial Production of Monoclonal Antibody Drugs 2016-10-17 22:40
New Research Shows Benefits of Fisher & Paykel Healthcare's Optiflow(TM) Nasal High Flow Therapy 2016-10-15 04:32
Changzhou Xinbei District Smart Home Care Service Center Starts Operation 2016-10-14 16:47
Moleac's Flagship Product NeuroAiD Named Asia Pacific Neurological Disorders New Product Innovation of the Year At the Frost & Sullivan Best Practices Awards 2016-10-14 00:01
Biostar Announces Execution of Agreement for $1.91 Million Registered Direct Offering of Shares of Common Stock and Warrants 2016-10-12 21:18
Data Presented at ESMO 2016 Demonstrates that VolitionRx Limited's Novel Blood Test for Colorectal Cancer Potentially Reduces the Need for Colonoscopy Referral by 25% 2016-10-11 20:30
China Biologic Receives CFDA Clinical Trial Approval for Human Antithrombin III 2016-10-11 20:30
Biostar to Launch a New Product Aimed at Treating Effects of Rhinitis and Sinusitis 2016-10-11 20:00
US FDA Grants Approval for LBT's APAS(R) 2016-10-10 18:00
1 339 340 341 342 343 800